PT - JOURNAL ARTICLE AU - Zhelv Yao AU - Chenglu Mao AU - Zhihong Ke AU - Yun Xu TI - An explainable machine learning model for predicting the outcome of ischemic stroke after mechanical thrombectomy AID - 10.1136/jnis-2022-019598 DP - 2022 Nov 29 TA - Journal of NeuroInterventional Surgery PG - jnis-2022-019598 4099 - http://jnis.bmj.com/content/early/2022/11/28/jnis-2022-019598.short 4100 - http://jnis.bmj.com/content/early/2022/11/28/jnis-2022-019598.full AB - Background There is high variability in the clinical outcomes of patients with acute ischemic stroke (AIS) after mechanical thrombectomy (MT).Methods 217 consecutive patients with anterior circulation large vessel occlusion who underwent MT between August 2018 and January 2022 were analysed. The primary outcome was functional independence defined as a modified Rankin Scale score of 0–2 at 3 months. In the derivation cohort (August 2018 to December 2020), 7 ensemble ML models were trained on 70% of patients and tested on the remaining 30%. The model’s performance was further validated on the temporal validation cohort (January 2021 to January 2022). The SHapley Additive exPlanations (SHAP) framework was applied to interpret the prediction model.Results Derivation analyses generated a 9-item score (PFCML-MT) comprising age, National Institutes of Health Stroke Scale score, collateral status, and postoperative laboratory indices (albumin-to-globulin ratio, estimated glomerular filtration rate, blood neutrophil count, C-reactive protein, albumin and serum glucose levels). The area under the curve was 0.87 for the test set and 0.84 for the temporal validation cohort. SHAP analysis further determined the thresholds for the top continuous features. This model has been translated into an online calculator that is freely available to the public (https://zhelvyao-123-60-sial5s.streamlitapp.com).Conclusions Using ML and readily available features, we developed an ML model that can potentially be used in clinical practice to generate real-time, accurate predictions of the outcome of patients with AIS treated with MT.Data are available upon reasonable request.